4,106 results on '"Bayes-Genis, A"'
Search Results
202. A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.
203. N‐terminal pro‐B‐type natriuretic peptide post‐discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study.
204. European Society of Cardiology Core Curriculum for cardio‐oncology.
205. The 'peptide for life' initiative in the emergency department study.
206. Personalizing anti‐inflammatory therapy in heart failure: a new way
207. State‐of‐the‐art document on optimal contemporary management of cardiomyopathies
208. Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT‐proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC
209. Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology
210. Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype–phenotype correlation
211. Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients : A Cohort Analysis
212. Nutritional Status According to the GLIM Criteria in Patients with Chronic Heart Failure: Association with Prognosis
213. NT-proBNP
214. Overlapping effects of miR-21 inhibition and drugs for idiopathic pulmonary fibrosis: rationale for repurposing nintedanib as a novel treatment for ischemia/reperfusion injury
215. Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean Cohort
216. Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
217. Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology
218. Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
219. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity
220. Characterization and classification of patients with different levels of cardiac death risk by using Poincaré plot analysis.
221. Proteomic signature of circulating extracellular vesicles in dilated cardiomyopathy
222. Primary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the “Codi IAM” Multicenter Registry)
223. Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure
224. Intermediate Care Unit After Cardiac Surgery: Impact on Length of Stay and Outcomes
225. Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
226. β-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study
227. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction
228. Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction
229. Gender-Related Differences in Heart Failure Biomarkers
230. Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
231. Management of Nonagenarian Patients With Severe Aortic Stenosis: The Role of Comorbidity
232. Magnetic Resonance Imaging-Guided Fibrosis Ablation for the Treatment of Atrial Fibrillation: The ALICIA Trial
233. Extracellular vesicle isolation methods: rising impact of size-exclusion chromatography
234. Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure
235. 1H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controls
236. Trends in Short‐ and Long‐Term ST‐Segment–Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean Population‐Based ST‐Segment–Elevation Myocardial Infarction Registry
237. New Electrocardiographic Algorithm for the Diagnosis of Acute Myocardial Infarction in Patients With Left Bundle Branch Block
238. Relationship Between Bioimpedance Vector Displacement and Renal Function After a Marathon in Non-elite Runners
239. First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft
240. Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
241. Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
242. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients
243. Head-to-head comparison of two engineered cardiac grafts for myocardial repair: From scaffold characterization to pre-clinical testing
244. Prognostic value of the Stanniocalcin-2/PAPP-A/IGFBP-4 axis in ST-segment elevation myocardial infarction
245. Deep Learning Analyses to Delineate the Molecular Remodeling Process after Myocardial Infarction
246. Quality over quantity: assessing the need for multiple biomarkers in predicting heart failure outcomes
247. Unlocking the potential of natriuretic peptide testing in primary care: A roadmap for early heart failure diagnosis
248. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
249. Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO‐HF trial
250. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.